Both in Pharmaceuticals
ABBVIE vs Bristol-Myers Squibb
Over the past year ABBV returned +35.2% and BMY returned +35.6%; their daily moves had a correlation of 0.49.
ABBV +35.2% BMY +35.6%Growth of $1, one year, split-adjusted
| Metric | ABBV | BMY |
|---|---|---|
| Price | $294.89 | $62.48 |
| Market cap | $521.11B | $127.71B |
| Today | +1.41% | +1.78% |
| 1 month | +13.4% | +1.7% |
| 6 months | +42.7% | +7.3% |
| Year to date | +29.1% | +15.8% |
| 1 year | +31.0% | +46.7% |
| Revenue growth (YoY) | +10.2% | +5.7% |
| Gross margin | 74.7% | 71.3% |
| Net margin | 21.3% | 25.6% |
| P/E (TTM) | 82.8× | 13.8× |
| Price / sales | 8.1× | 2.6× |
| Net cash | -$64.25B | -$32.05B |
| Dividend yield | 2.35% | 4.03% |
| Volatility (60d) | 19.6% | 27.3% |
| Short % of float | 0.9% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).